FSLLRY-NH2 (TFA)-5 mg

Description

FSLLRY-NH2 TFA is a protease-activated receptor 2 (PAR2) inhibitor[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–Neuroscience-Neuromodulation–C41H61F3N10O10—-[1]Umut Ocak, et al. FSLLRY-NH2 Improves Neurological Outcome After Cardiac Arrest in Rats. Turk Neurosurg. 2020;30(2):244-251.—-910.98–99.43–OC1=CC=C(C=C1)C[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CC2=CC=CC=C2)N)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F–Neurological Disease–DMSO : 100 mg/mL (ultrasonic)|H2O : 1.43 mg/mL (ultrasonic)–Protease Activated Receptor (PAR)–PAR2–GPCR/G Protein–Peptides